The targeted histone deacetylase inhibitor tefinostat (CHR-2845) shows selective in vitro efficacy in monocytoid-lineage leukaemias

Tefinostat (CHR-2845) is a novel monocyte/macrophage-targeted histone deacetylase (HDAC) inhibitor which is cleaved into its active acid by the intracellular esterase human carboxylesterase-1 (hCE-1). The in vitro efficacy of tefinostat was characterised in cell lines and in a cohort of 73 primary A...

Descripción completa

Detalles Bibliográficos
Autores principales: Zabkiewicz, Joanna, Gilmour, Marie, Hills, Robert, Vyas, Pares, Bone, Elizabeth, Davidson, Alan, Burnett, Alan, Knapper, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941341/
https://www.ncbi.nlm.nih.gov/pubmed/26934551
http://dx.doi.org/10.18632/oncotarget.7692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941341/
https://www.ncbi.nlm.nih.gov/pubmed/26934551
http://dx.doi.org/10.18632/oncotarget.7692

Ejemplares similares